The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Pregnen-21-ol-3,20-dione-21-(4-nitrobenzenesufonate) ID: ALA1093760
PubChem CID: 44550019
Max Phase: Preclinical
Molecular Formula: C27H33NO7S
Molecular Weight: 515.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)COS(=O)(=O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C27H33NO7S/c1-26-13-11-19(29)15-17(26)3-8-21-22-9-10-24(27(22,2)14-12-23(21)26)25(30)16-35-36(33,34)20-6-4-18(5-7-20)28(31)32/h4-7,15,21-24H,3,8-14,16H2,1-2H3/t21-,22-,23-,24+,26-,27-/m0/s1
Standard InChI Key: CSFFQWPGTTYNBO-YNHSGCSHSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
5.4603 -9.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4603 -9.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1720 -8.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1720 -10.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8879 -9.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6038 -10.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3196 -9.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3196 -9.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0313 -8.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8160 -8.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3007 -8.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8156 -7.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2285 -6.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0527 -6.7921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0313 -7.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0313 -6.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3196 -7.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6038 -7.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6038 -8.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8879 -9.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8879 -8.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6038 -9.4125 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.3196 -8.1750 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
9.0313 -9.4125 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
4.7455 -10.2369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8146 -6.0815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4624 -6.0762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2864 -6.1165 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.1099 -6.1075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2708 -6.9414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3037 -5.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5276 -6.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3502 -6.8098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7550 -6.0916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3310 -5.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5097 -5.3928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5825 -6.0819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9862 -5.3624 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0037 -6.7913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9 15 1 0
15 16 1 1
15 17 1 0
17 18 1 0
18 19 1 0
8 19 1 0
19 20 1 0
3 20 1 0
5 20 1 0
20 21 1 1
19 22 1 6
8 23 1 1
9 24 1 6
1 25 2 0
1 2 1 0
13 26 2 0
2 3 1 0
14 27 1 0
1 4 1 0
27 28 1 0
4 5 2 0
28 29 1 0
5 6 1 0
28 30 2 0
6 7 1 0
28 31 2 0
7 8 1 0
29 32 2 0
8 9 1 0
32 33 1 0
9 10 1 0
33 34 2 0
10 11 1 0
34 35 1 0
11 12 1 0
35 36 2 0
36 29 1 0
12 13 1 1
13 14 1 0
12 15 1 0
37 38 2 0
37 39 1 0
34 37 1 0
M CHG 2 37 1 39 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.63Molecular Weight (Monoisotopic): 515.1978AlogP: 5.02#Rotatable Bonds: 6Polar Surface Area: 120.65Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.32CX LogD: 5.32Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.30Np Likeness Score: 0.84
References 1. Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, Marchand C, Interthal H, Nicklaus M, Fisher RJ, Njar VC, Pommier Y.. (2009) 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors., 52 (22): [PMID:19883083 ] [10.1021/jm901061s ]